Abstract
In the present study, the regulation of the mRNA of 11 sulfotransferases (Sults) and two 3′-phosphoadenosine 5′-phosphosulfate synthase (PAPSs) isozymes by 15 microsomal enzyme inducers (MEI) in livers of male mice and five MEIs in livers of female mice was examined. These MEIs represent the transcriptionally mediated pathways: aryl hydrocarbon receptor (AhR), pregnane X receptor (PXR), constitutive androstane receptor (CAR), peroxisomal proliferator-activated receptor α (PPARα), and NF-E2-related factor 2 (Nrf2). AhR ligands suppress the expression of Sults, especially the Sult1 isoenzymes in female mice. CAR activators up-regulate several Sults and PAPSs2 in female but not in male mice. PXR ligands cause marked induction of Sult1e1 in male, Sult2a1/2a2 in female, and PAPSs2 in both male and female mice. PPARα ligands do not have a marked effect on Sult expression in males, but they tend to suppress the expression of several Sult isoforms in female mice. Nrf2 activators appear to induce the mRNA expression of Sults in male and have mixed effects in female mice. In silico analysis indicated the presence of putative binding sites for all five transcription factors in the promoter region of many Sult and PAPSs isoforms. In conclusion, induction of Sults by typical MEIs is not as marked as the induction of P450 enzymes in mice. In addition to gender differences in basal expression of Sults, there is also a marked gender difference in the inducibility of various Sult isoenzymes in mice by MEIs.
Footnotes
-
This work was supported by National Institutes of Health Grants ES-09649 and ES-09716 and Centers of Biomedical Research Excellence Grant P20-RR-021940.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.107.129650.
-
ABBREVIATIONS: Sult, sulfotransferase; bDNA, branched DNA signal amplification assay; PAPS, 3′-phosphoadenosine,5′phosphosulfate; PAPSs, PAPS synthase; RLU, relative light unit(s); AhR, hydrocarbon receptor; CAR, constitutive androstane receptor; PXR, pregnane X receptor; PPARα, peroxisome proliferator-activated receptor α; Nrf2, NF-E2-related factor 2; BNF, β-naphthoflavone; MEI, microsomal enzyme inducer; TCDD, 2,3,7,8-Tetrachlorodibenzo-p-dioxin; OPZ, oltipraz; PCB126, polychlorinated biphenyl 126; DAS, diallyl sulfide; CLOF, clofibric acid; DEX, dexamethasone; EXQ, ethoxyquin; PCN, pregnenolone-16α-carbonitrile; BHA, butylated hydroxyanisole; SPR, spironolactone; TCPOBOP, 1,4-bis[2-(3,5-dichloropuridyloxy)]benzene; 3MC, 3-methylcholanthrene; LCA, lithocholic acid.
- Received August 2, 2007.
- Accepted November 8, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|